|
|
||||||||
Ann Thorac Surg 2003;76:654-655
© 2003 The Society of Thoracic Surgeons
a Department of Cardiothoracic Surgery, Thorax Center, University Hospital Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands
e-mail: y.j.gu{at}med.rug.nl
To the Editor:
We read with interest the recent article by Franke and co-workers [1] on the postoperative proinflammatory and anti-inflammatory responses after cardiac operation with cardiopulmonary bypass (CPB). On the basis of their findings of several proinflammatory and anti-inflammatory cytokines, they described a postoperative biphasic immune response. However, two major limitations of their study are the use of isolated cell cultures and the lack of clinical relevance.
In fact, there are clinically relevant monocyte membrane markers discussed in the literature that directly indicate the status of the body host defense known as the anti-inflammatory profile [25]. One of these markers is the histocompatibility leukocyte antigen-DR (HLA-DR), the levels of which can be determined by flow cytometry. It is known that on activation, monocytes release different sorts of proinflammatory and anti-inflammatory cytokines, as shown in the work of Franke and colleagues [1]. After activation, however, the defense ability of monocytes is impaired as these cells express fewer surface HLA-DR receptors. Expression of HLA-DR on monocytes is thus considered an ideal marker for monitoring the status of a patients anti-inflammatory profile, especially that of a patient at risk.
We recently studied a group of high-risk cardiac surgical patients who had compromised preoperative renal function as indicated by elevated serum creatinine levels. Monocyte HLA-DR expression was determined by a whole-blood cytometric assay using a fluorescence-activated cell sorter. Blood samples were taken before, during, and after operation until postoperative day 7. We found that anesthesia and surgical trauma before CPB caused a marked reduction in monocyte HLA-DR expression (Fig 1). Within the first 30 minutes of CPB, only a slight drop in HLA-DR expression was observed, whereas it had dropped significantly by the end of CPB. After operation, monocyte HLA-DR expression remained low during the first 2 hours in the intensive care unit, and this low level persisted on postoperative day 1. The lowest level of HLA-DR expression on monocytes was observed on postoperative day 2. By postoperative day 7, it had partially recovered, though, was still much lower than the preoperative baseline.
|
According to the study of Franke and associates [1], cardiac operation with CPB stimulates the release of proinflammatory and anti-inflammatory cytokines from different cellular sources at different times. Our data further specify that after contributing to both proinflammatory and anti-inflammatory responses by releasing different cytokines in the early postoperative phase, monocytes can become exhausted and lose their host defense ability in the second postoperative phase. Once monocytes have lost their defense function, as appeared in our patients with continuously depressed monocyte HLA-DR expression, the consequences can be serious. Postoperative organ dysfunction and infection can develop as a result of a fragile host defense.
References
This article has been cited by other articles:
![]() |
A. Franke, W. Lante, L. G. Zoeller, E. Kurig, C. Weinhold, and A. Markewitz Delayed recovery of human leukocyte antigen-DR expression after cardiac surgery with early non-lethal postoperative complications: only an epiphenomenon? Interactive CardioVascular and Thoracic Surgery, April 1, 2008; 7(2): 207 - 211. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |